title: Protein-losing enteropathy in a dog with lymphangiectasia, lymphoplasmacytic enteritis and pancreatic exocrine insufficiency.
abstract: This is a report of seven-year-old male Akita mixed dog, with protein-losing enteropathy (PLE). He had a history of chronic vomiting and diarrhea with anorexia/hyporexia. Previously he suffered acute abdomen about eight months prior to this visit. Our dog showed uncommon combination of diseases that could cause PLE since it was affected by inflammatory bowel disease (IBD), intestinal lymphangiectasia (IL), and exocrine pancreatic insufficiency (EPI). The dog had most of the abnormalities found in IL, as well as hypoalbuminemia, hyperglobulinemia, lymphopenia, hypocalcemia, and hypercholesterolemia. During endoscopy exam, we found changes characteristic of IL such as irregular small white spots. We took biopsies from stomach, duodenum, and cecum. These biopsies showed infiltration by lymphocytes and plasmatic cells in the lamina propria also, the duodenal biopsies showed moderate dilation of the lymphatic vessels. The patient had 2.1 µg/mL of TLI, this result was compatible with EPI. We assume that the first pathology in this animal was IBD, which caused chronic pancreatitis (CP) that in turn progressed to EPI. It is also possible that IL was secondary to IBD. We have reported for the first time the correlation of IBD and EPI in dogs. This should change our approach to treating chronic diarrhea in dogs. Therefore, we propose that dogs diagnosed with EPI should also be subjected to endoscopy and intestinal biopsy. Similarly, to rule out secondary EPI, TLI should be measured routinely in dogs with IBD.
authors.affiliation: Veterinary Science Department, Veterinary Hospital, Autonomous University of Juarez, Mexico. carrodri@uacj.mx
authors.forename: C A
authors.initials: CA
authors.lastname: Rodríguez-Alarcón
authors.forename: D M
authors.initials: DM
authors.lastname: Beristaín-Ruiz
authors.forename: F
authors.initials: F
authors.lastname: Pérez-Casio
authors.forename: R
authors.initials: R
authors.lastname: Rivera
authors.forename: G
authors.initials: G
authors.lastname: Ochoa
authors.forename: U
authors.initials: U
authors.lastname: Martín-Orozco
mesh_terms: D000818:Animals; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy / Q000662:veterinary; D003131:Combined Modality Therapy / Q000662:veterinary; D004032:Diet / Q000662:veterinary; D004283:Dog Diseases / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D004285:Dogs; D004724:Endoscopy / Q000662:veterinary; D010188:Exocrine Pancreatic Insufficiency / Q000150:complications / Q000175:diagnosis / Q000628:therapy / Q000662:veterinary*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015212:Inflammatory Bowel Diseases / Q000150:complications / Q000175:diagnosis / Q000628:therapy / Q000662:veterinary*; D008201:Lymphangiectasis, Intestinal / Q000150:complications / Q000175:diagnosis / Q000628:therapy / Q000662:veterinary*; D008297:Male; D011504:Protein-Losing Enteropathies / Q000175:diagnosis / Q000209:etiology / Q000628:therapy / Q000662:veterinary*; D016896:Treatment Outcome; D014357:Trypsin / Q000378:metabolism; D015431:Weight Loss
chemical_list: D007166:Immunosuppressive Agents; D014357:Trypsin; D001379:Azathioprine